-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

636. Myelodysplastic Syndromes – Basic and Translational Studies: Poster II

Myelodysplastic Syndromes – Basic and Translational Studies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Magnus Tobiasson, MD1*, Donal McLornan, MD PhD2*, Mohsen Karimi3*, Marios Dimitriou, PhD3*, Monika Jansson3*, Asmaa Ben Azenkoud4*, Martin Jädersten1*, Greger Lindberg5*, Hani Abdulkadir6*, Austin G. Kulasekararaj, MBBS, MD, MRCP, FRCPath7*, Johanna Ungerstedt, Associate Professor6*, Andreas Lennartsson8*, Karl Ekwall8*, Ghulam J Mufti9 and Eva Hellström-Lindberg, MD, PhD10*

1Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Sweden, Stockholm, Sweden
2Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust, London, United Kingdom
3Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet,, Stockholm, Sweden
4asmaa.ben.azenkoud@ki.se, Stockholm, Sweden
5Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Sweden, Stockholm, Sweden
6Department of Medicine Huddinge, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden
7Department of Haematological Medicine, Kings College Hospital NHS Foundation Trust, London, United Kingdom
8Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden
9Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust, London, United Kingdom, London, United Kingdom
10Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

Francoise Solly, MD1*, Catherine Koering, PhD2*, Aminetou mint Mohamed, PhD3*, Delphine Maucort-Boulch, MD4*, Guillaume Robert, PhD5*, Patrick Auberger, PhD5*, Pascale Flandrin-Gresta, MD PhD1*, Lionel Adès, MD, PhD6*, Pierre Fenaux, MD, PhD7, Olivier Kosmider, MD, PhD8*, Emmanuelle Tavernier-Tardy, MD PhD1*, Jérôme Cornillon, MD9*, Denis Guyotat, MD PhD1*, Lydia Campos, MD, PhD10, Franck Mortreux, PhD11* and Eric Wattel, MD PhD11

1Saint-Etienne University Hospital, Saint-Etienne, France
2Lyon I University, Pierre-Bénite, France
3Lyon I University, France, France
4Lyon I University, Lyon, China
5Inserm U1065, Nice, France, Nice, France
6Hospital St Louis, Paris 7 University, Paris, France
7Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
8APHP Laboratoire d'Hématologie, Hôpital Cochin, Paris, France
9Department of Hematology, Saint-Etienne University Hospital, Saint-Etienne, France
10Laboratoire Hematologie, Hopital Nord, Saint-Etienne, France
11Lyon I University, Lyon, France

Yosaku Watatani, MD1*, Yasunobu Nagata, MD, Ph.D.2*, Vera Grossmann, MSc3, Yusuke Okuno, MD, Ph.D.4*, Tetsuichi Yoshizato, MD2*, Yusuke Shiozawa, MD2*, Genta Nagae, MD, PhD5*, Kenichi Yoshida, MD, Ph.D.2*, Keisuke Kataoka, MD, PhD2*, Susanne Schnittger, PhD3, Masashi Sanada, MD, Ph.D.6*, Ayana Kon, MD, Ph.D.2*, Yuichi Shiraishi, MD, Ph.D.7*, Kenichi Chiba, BA7*, Hiroko Tanaka, BA7*, Tsuyoshi Nakamaki, MD8, Shuichi Miyawaki, MD9, Shigeru Chiba, M.D., Ph.D.10, Tamara Alpermann3*, Niroshan Nadarajah, M.Sc.3*, Phillip Koeffler, MD11, Hans-Ulrich Klein12*, Martin Dugas13*, Hiroyuki Aburatani, MD, PhD5*, Claudia Haferlach, MD3, Wolfgang Kern, MD3, Satoru Miyano, MD, Ph.D.7*, Lee-Yung Shih, MD14, Seishi Ogawa, MD, Ph.D.2, Torsten Haferlach3 and Hideki Makishima, MD, Ph.D.2

1Department of Pathology and Tumor biology,, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3MLL Munich Leukemia Laboratory, Munich, Germany
4Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
5Genome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan
6Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
7Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
8Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
9Japan Adult Leukemia Study Group, Hamamatsu, Japan
10Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
11Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA
12Institute of Medical Informatics, University of Münster, Münster, Germany
13Institute of Medical Informatics, University of Munster, Munster, Germany
14Department of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, College of Medicine Chang Gung University, Taipei, Taiwan

Gina Westhofen1*, Christina Ganster1*, Fabian Beier, MD2*, Tienush Rassaf3*, Haifa Kathrin Al-Ali, MD4*, Reingard Stuhlmann5*, Ulrike Bacher1*, Tim H. Brümmendorf6, Ulrich Germing, MD7*, Norbert Gattermann, MD8 and Detlef Haase, MD1*

1Department of Hematology and Medical Oncology, Georg-August-University Göttingen, Göttingen, Germany
2Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany
3Department of Cardiology, Pneumology, Angiology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
4University of Leipzig, Leipzig, Germany
5Asklepios Klinik St. Georg, Hamburg, Germany
6Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany
7Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany
8Dept. of Hematology, Oncology, and clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany

June Takeda, MD1*, Kenichi Yoshida, MD, Ph.D.1*, Hideki Makishima, MD, Ph.D.1, Tetsuichi Yoshizato, MD1*, Yusuke Shiozawa, MD1*, Yuichi Shiraishi, MD, Ph.D.2*, Yusuke Okuno, MD, Ph.D.3*, Ayana Kon, MD, Ph.D.1*, Yasunobu Nagata, MD, Ph.D.1*, Keisuke Kataoka, MD, Ph.D.1*, Kenichi Chiba, BA2*, Hiroko Tanaka, BA2*, Masashi Sanada, MD, Ph.D.4*, Mamiko Sakata-Yanagimoto, MD, Ph.D.5*, Naoshi Obara, MD, Ph.D.5*, Tsuyoshi Nakamaki, MD6, Ken Ishiyama, MD, Ph.D.7, Akira Haigaishi, MD, Ph.D.8*, Shigeru Chiba, M.D., Ph.D.5, Hiraku Mori, MD, Ph.D.6*, Norio Asou, MD, Ph.D.9, Hitoshi Kiyoi, MD10, Chikara Hirase, MD, Ph.D.11*, Kiyotoshi Imai, MD, Ph.D.12*, Nobuaki Dobashi, MD13, Toru Kiguchi, MD, Ph.D.14*, Yasushi Miyazaki, MD, Ph.D.15, Tomoki Naoe, MD, Ph.D.16, Satoru Miyano, MD, Ph.D.2*, Kensuke Usuki, MD, Ph.D.8*, Shuichi Miyawaki, MD, Ph.D.17, Yoichiro Kamatani, MD, Ph.D.18*, Yukihide Momozawa, MD, Ph.D.18*, Michiaki Kubo, MD, Ph.D.18*, Chantana Polprasert, MD19*, Jaroslaw P. Maciejewski, MD, Ph.D.20 and Seishi Ogawa, MD, Ph.D.1

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
3Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
4Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
5Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan
6Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
7Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
8Deptartment of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
9Department of Hematology, Saitama Medical University International Medical Center, Hidaka, Japan
10Department of Hematology and Oncology, Nagoya University, Nagoya, Japan
11Department of Hematology and Rheumatology, Kinki University, Osaka-Sayama, Japan
12Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
13Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
14Department of Hematology, Chugoku Central Hospital of the Mutual Aid Association of Public School Teachers, Hiroshima, Japan
15Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
16National Hospital Organization Nagoya Medical Center, Nagoya, Japan
17Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan
18RIKEN, Saitama, Japan
19Department of Translational Hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, Cleveland, OH
20Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Yang Jo Chung, PhD1, Suntae Kim, Ph. D2*, Zhenhua Zhang, MD2* and Peter D. Aplan, MD3

1Genetics Branch, NIH/NCI/CCR, Bethesda, MD
2NIH/NCI/CCR, Bethesda, MD
3NCI/CCR/Genetics branch, National Institutes of Health, Bethesda, MD

Akiko Nagamachi, Ph.D.1*, Yuko Ozaki, Ph.D.1*, Hirotaka Matsui, MD, PhD2, Akinori Kanai, Ph.D.1* and Toshiya Inaba, MD1

1Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
2Department of Molecular Laboratory Medicine, Kumamoto University, Kumamoto, Japan

Maria Feola, MS1,2*, Tenzin Choesang, MS1*, Weili Bao, MS1*, Li Huihui, MS1,3*, Huiyong Chen, PhD1*, Shuming Sun, PhD1*, Petra Pham, MS4*, Guiyuan Li, MD3*, Amit Verma, MD5, Antonia Follenzi, MD PhD2* and Yelena Ginzburg, MD1

1New York Blood Center, New York, NY
2University of Piemonte Orientale, Amedeo Avogadro, Novara, Italy
3Cancer Research Institute, Central South University, Changsha, China
4Platelet Biology Laboratory, New York Blood Center, New York, NY
5Department of Medicine-Oncology, Albert Einstein College of Medicine, Bronx, NY

Fernanda Marconi Roversi, PhD1*, Nathalia Moreno Cury, MSc2*, Matheus Rodrigues Lopes, MSc1*, Fernando Vieira Pericole, M.D.1*, Marisa Claudia Alvarez Prax, PhD1*, Karla Priscila Ferro, PhD1*, Patricia Favaro, PhD1*, José Andres Yunes, PhD2* and Sara T Saad, M.D., PhD1

1Hematology and Hemotherapy Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil
2Centro Infantil Boldrini, Campinas, São Paulo, Brazil

Bhumika J. Patel1*, Bartlomiej Przychodzen, MSc2*, Michael J. Clemente3*, Cassandra M. Hirsch2*, Tomas Radivoyevitch, PhD4*, Swapna Thota, MD1*, Thomas LaFramboise, PhD5*, Hirotoshi Sakaguchi, MD, PhD6*, Seiji Kojima, MD, PhD7*, Hetty E. Carraway, MD, MBA8, Mikkael A. Sekeres, MD, MS8, Seishi Ogawa, MD, Ph.D.9, Hideki Makishima, MD, Ph.D.9 and Jaroslaw P. Maciejewski, MD, Ph.D.1

1Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH
3Taussig Cancer Institute, Cleveland Clinic, Translational Hematology Oncology Research, Cleveland, OH
4Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
5Electrical Engineering and Computer Science, Case Western Reserve University, Cleveland, OH
6Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
7Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
8Leukemia Program, Cleveland Clinic, Cleveland, OH
9Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Niroshan Nadarajah, M.Sc.*, Manja Meggendorfer, PhD*, Wolfgang Kern, MD, Claudia Haferlach, MD and Torsten Haferlach

MLL Munich Leukemia Laboratory, Munich, Germany

Samuel Ojo Abegunde, MD, BSc, MBBS* and Michael J. Rauh, MD, PhD

Department of Pathology & Molecular Medicine, Queen's University, Kingston, ON, Canada

Pier Paolo Leoncini, PhD1*, Alice Bertaina, MD, PhD2, Dimitrios Papaioannou, MD3*, Christian Flotho4*, Riccardo Masetti, MD5*, Silvia Bresolin, PhD6*, Giuseppe Menna, MD7*, Nicola Santoro8*, Marco Zecca, MD9*, Giuseppe Basso, Prof, MD6, Giovanni Nigita, PhD10*, Sara Pagotto, PhD11*, Katia D'Ovidio, PhD12*, Rossella Rota13*, Carlo M. Croce, MD14, Charlotte Marie Niemeyer, Prof, MD15, Franco Locatelli, MD, PhD2 and Ramiro Garzon, MD16

1Deèartment of Pediatric Hematology, Ospedale Pediatrico Bambino Gesù, Rome, Italy
2Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
3Division of Hematology, Comprehensive Cancer center, The Ohio State university, Columbus
4Pediatrics, University of Freiburg, Freiburg, Germany
5Pediatric Oncology and Hematology, University of Bologna, Bologna, Italy
6Woman and Child Health Department, University of Padova, Padova, Italy
7Pediatric Hematology, Ospedale Pausillipon, Naples, Italy
8Policlinico di Bari, Bari, Italy
9Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
10Ohio State University, Columbus, OH
11Unit of General Pathology, Aging Research Center (Ce.S.I.), G. d'Annunzio University Foundation, Chieti, Italy
12Ospedale Pediatrico Bambino Gesù, Rome, Italy
13Pediatric Hematology, Ospedale Pediatrico Bambino Gesù, Rome, Italy
14The Ohio State University Comprehensive Cancer Center, Columbus, OH
15Children's Hospital, University Medical Center, Freiburg, Germany
16Comprehensive Cancer Center, The Ohio State University, Columbus, OH

Irene Gañán-Gómez, PhD1*, Yamini Ogoti1*, Matteo Marchesini, PhD1*, Yue Wei, PhD1, Hui Yang, MD, PhD1, Shan Jiang2*, Naran Bao1*, Carlos E. Bueso-Ramos, MD3, Guillermo Garcia-Manero, MD4 and Simona Colla, PhD1*

1Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
2Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Eiju Negoro, MD, PhD1*, Chantana Polprasert, MD2*, Tomas Radivoyevitch, PhD3*, Vera Adema4*, Naoko Hosono, MD, PhD.5*, Hideki Makishima, MD, Ph.D.6, Bartlomiej Przychodzen, MSc1*, Mikkael A. Sekeres, MD, MS7, Valeria Santini, MD8, Kathy McGaw9*, Alan F. List, MD9, Francesc Sole, PhD4 and Jaroslaw P. Maciejewski, MD, Ph.D.10

1Department of Translational Hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
3Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
4Josep Carreras Leukaemia Research Institute, Barcelona, Spain
5Department of Hematology and Oncology, University of Fukui, Fukui, Japan
6Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
7Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
8AOU Careggi, University of Florence, Florence, Italy
9Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
10Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Yuesheng Meng, MD PhD, Fanli Hua, MD PhD*, Ying Li, MD* and Song Gao, MD*

Dept of Hematology, Fudan University Jinshan Hospital, Shanghai, China

Lisa J. McReynolds, MD, PhD1, Peter D. Aplan, MD2, Donald Small, MD, PhD3, Li Ding, MD4*, Kirby D. Johnson5*, Emery H Bresnick, Ph.D.5 and Steven M. Holland, MD1*

1Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
2NCI/CCR/Genetics branch, National Institutes of Health, Bethesda, MD
3Department of Oncology and Pediatrics, Johns Hopkins University, Baltimore, MD
4Laboratory of Clinical Infectious Diseases, National Institue of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
5Department of Cell and Regenerative Biology, Carbone Cancer Center, UW-Madison Blood Research Program, University of Wisconsin School of Medicine and Public Health, Madison, WI

Wolfgang Kern, MD1, Manja Meggendorfer, PhD1*, Seishi Ogawa, MD, Ph.D.2, Claudia Haferlach, MD1, Susanne Schnittger, PhD1 and Torsten Haferlach1

1MLL Munich Leukemia Laboratory, Munich, Germany
2Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Chunkang Chang, MD, PhD*, Chengming Fei, MD*, Juan Guo, MD*, Youshan Zhao, MD*, Shucheng Gu, MD* and Xiao Li, MD, PhD

Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

Anne-Sophie Bouillon1*, Monica S. Ferreira, PhD1*, Benjamin Werner, PhD2,3*, Sebastian Hummel1*, Jens P. Panse, MD1, Petra Reinecke, MD4*, Jennifer Schemenau5*, Rainer Haas, MD6*, Arne Traulsen, PhD3*, Tim H. Bruemmendorf, MD1, Ulrich Germing, MD6* and Fabian Beier, MD1*

1Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany
2Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom
3Department of Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Plön, Germany
4Institute of Pathology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
5Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany
6Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

Maximilian Mossner1*, Alexandra Stoehr1*, Johann-Christoph Jann1*, Florian Nolte, MD2*, Verena Nowak1*, Julia Oblaender1*, Jovita Pressler1*, Christina Xanthopoulos1*, Iris Palme1*, Claudia D Baldus, MD3, Torsten Schulze, MD4*, Tobias Boch, MD1*, Georgia Metzgeroth, MD1*, Martin Neumann, MD3*, Wolf-Karsten Hofmann, MD1 and Daniel Nowak, MD1*

1Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
2St. Hedwig-Krankenhaus, Berlin, Germany
3Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany
4Department of Transfusion Medicine, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany

Fernanda Marconi Roversi, PhD1*, Fernando Vieira Pericole, M.D.1*, Adriana da Silva Santos Duarte, Ph.D.1*, Karla Priscila Ferro, PhD1*, Flávia Adolfo Corrocher, MSc1*, Bruna Palodetto, MSc1*, Ana Leda Longhini, PhD1*, Maurizio Botta, PhD2* and Sara T Saad, M.D., PhD1

1Hematology and Hemotherapy Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, São Paulo, Brazil
2Department of biotechnology, chemistry and pharmacy, University of Siena, Siena, Italy

*signifies non-member of ASH